Table 2.

Risk of in-hospital mortality stratified by anatomical location of primary procedure. Data presented as n (%). ∗Numbers suppressed to maintain patient anonymity. Risk of in-hospital mortality stratified by surgical specialty. Organ donation removed given low numbers. GI; gastrointestinal; HPB, hepatopancreatobiliary; LGU, lower genitourinary; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UGU, upper genitourinary.

	SARS-CoV-2 infection		No SARS-CoV-2 infection
	n	In-hospital death	n	In-hospital death
Bone	3417	815 (23.9%)	132 180	1909 (1.4%)
Breast	43	∗ (%∗)	56 450	12 (0.0%)
Cardiac	2374	313 (13.2%)	153 894	2609 (1.7%)
Cerebrovascular	116	21 (18.1%)	4769	211 (4.4%)
Ear	56	10 (17.9%)	27 756	28 (0.1%)
Endocrine	46	∗ (%∗)	14 778	32 (0.2%)
Female LGU	48	∗ (%∗)	24 587	19 (0.1%)
Female UGU	348	∗ (%∗)	128 201	51 (0.0%)
HPB	752	120 (16.0%)	74 445	723 (1.0%)
Joint	3067	755 (24.6%)	196 034	1860 (0.9%)
Lower GI	2393	422 (17.6%)	227 230	2369 (1.0%)
Major vessel	457	112 (24.5%)	19 330	819 (4.2%)
Male GU	126	19 (15.1%)	33 521	68 (0.2%)
Muscle	157	26 (16.6%)	56 427	84 (0.1%)
Nasal	181	36 (19.9%)	48 691	106 (0.2%)
Neurological	1675	436 (26.0%)	123 866	2654 (2.1%)
Obstetrics	2489	∗ (%∗)	215 432	11 (0.0%)
Ocular	133	∗ (%∗)	376 152	40 (0.0%)
Oral	130	19 (14.6%)	83 209	71 (0.1%)
Orthopaedics	30	∗ (%∗)	13 823	11 (0.1%)
Other	395	111 (28.1%)	32 119	564 (1.8%)
Pharynx	45	9 (20.0%)	15 182	48 (0.3%)
Skin	1475	325 (22.0%)	233 798	1059 (0.5%)
Skull and spine	335	39 (11.6%)	62 216	279 (0.4%)
Thoracic	4722	1503 (31.8%)	20 185	1122 (5.6%)
Upper GI	999	258 (25.8%)	33 128	1228 (3.7%)
Urological	978	208 (21.3%)	165 758	816 (0.5%)
Vascular	1790	562 (31.4%)	65 040	1408 (2.2%)